MCL coexpression mm9:416
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr10:5734717..5734727,- | p12@Esr1 |
Mm9::chr10:75399907..75399919,+ | p@chr10:75399907..75399919 + |
Mm9::chr12:16596549..16596632,- | p1@Lpin1 |
Mm9::chr12:72977020..72977051,+ | p@chr12:72977020..72977051 + |
Mm9::chr15:76137124..76137135,- | p@chr15:76137124..76137135 - |
Mm9::chr18:64639050..64639061,- | p@chr18:64639050..64639061 - |
Mm9::chr3:129234914..129234917,- | p@chr3:129234914..129234917 - |
Mm9::chr4:147976089..147976106,+ | p@chr4:147976089..147976106 + |
Mm9::chr5:125976345..125976366,+ | p@chr5:125976345..125976366 + |
Mm9::chr5:66473042..66473055,- | p@chr5:66473042..66473055 - |
Mm9::chr6:142421318..142421325,- | p8@Gys2 |
Mm9::chr6:142421333..142421360,- | p5@Gys2 |
Mm9::chr6:142421364..142421402,- | p2@Gys2 |
Mm9::chr6:142421417..142421436,- | p4@Gys2 |
Mm9::chr6:142421480..142421505,- | p3@Gys2 |
Mm9::chr7:148021087..148021088,+ | p7@1190003J15Rik |
Mm9::chr8:113560785..113560799,+ | p@chr8:113560785..113560799 + |
Mm9::chr9:106150191..106150205,- | p1@Alas1 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0031529 | ruffle organization and biogenesis | 0.0124236528193307 |
GO:0019842 | vitamin binding | 0.0124236528193307 |
GO:0032868 | response to insulin stimulus | 0.0124236528193307 |
GO:0043434 | response to peptide hormone stimulus | 0.0124236528193307 |
GO:0032870 | cellular response to hormone stimulus | 0.0124236528193307 |
GO:0045839 | negative regulation of mitosis | 0.0124236528193307 |
GO:0016749 | N-succinyltransferase activity | 0.0124236528193307 |
GO:0004373 | glycogen (starch) synthase activity | 0.0124236528193307 |
GO:0032869 | cellular response to insulin stimulus | 0.0124236528193307 |
GO:0003870 | 5-aminolevulinate synthase activity | 0.0124236528193307 |
GO:0031532 | actin cytoskeleton reorganization | 0.0133092333762021 |
GO:0016748 | succinyltransferase activity | 0.0133092333762021 |
GO:0004813 | alanine-tRNA ligase activity | 0.0133092333762021 |
GO:0006419 | alanyl-tRNA aminoacylation | 0.0133092333762021 |
GO:0006590 | thyroid hormone generation | 0.0206975809343111 |
GO:0035251 | UDP-glucosyltransferase activity | 0.0219120840674093 |
GO:0008195 | phosphatidate phosphatase activity | 0.0219120840674093 |
GO:0046527 | glucosyltransferase activity | 0.0241405635418043 |
GO:0019841 | retinol binding | 0.0248268930780587 |
GO:0045598 | regulation of fat cell differentiation | 0.0248268930780587 |
GO:0042403 | thyroid hormone metabolic process | 0.0260103751302593 |
GO:0016918 | retinal binding | 0.0260103751302593 |
GO:0006519 | amino acid and derivative metabolic process | 0.0260103751302593 |
GO:0009250 | glucan biosynthetic process | 0.0260103751302593 |
GO:0005978 | glycogen biosynthetic process | 0.0260103751302593 |
GO:0006783 | heme biosynthetic process | 0.0260103751302593 |
GO:0009058 | biosynthetic process | 0.0260103751302593 |
GO:0033014 | tetrapyrrole biosynthetic process | 0.0260103751302593 |
GO:0006779 | porphyrin biosynthetic process | 0.0260103751302593 |
GO:0005501 | retinoid binding | 0.0260103751302593 |
GO:0019840 | isoprenoid binding | 0.0260103751302593 |
GO:0009308 | amine metabolic process | 0.0271903979283695 |
GO:0009725 | response to hormone stimulus | 0.0286942308675125 |
GO:0042168 | heme metabolic process | 0.0286942308675125 |
GO:0006807 | nitrogen compound metabolic process | 0.0286942308675125 |
GO:0033692 | cellular polysaccharide biosynthetic process | 0.0293600272437102 |
GO:0033013 | tetrapyrrole metabolic process | 0.0293600272437102 |
GO:0006778 | porphyrin metabolic process | 0.0293600272437102 |
GO:0000271 | polysaccharide biosynthetic process | 0.0301923598486603 |
GO:0051716 | cellular response to stimulus | 0.0309826520203106 |
GO:0045444 | fat cell differentiation | 0.0347467450100203 |
GO:0046148 | pigment biosynthetic process | 0.0373293804433897 |
GO:0007088 | regulation of mitosis | 0.0373293804433897 |
GO:0000902 | cell morphogenesis | 0.0373293804433897 |
GO:0032989 | cellular structure morphogenesis | 0.0373293804433897 |
GO:0006073 | glucan metabolic process | 0.0399590170377478 |
GO:0005977 | glycogen metabolic process | 0.0399590170377478 |
GO:0042440 | pigment metabolic process | 0.0399590170377478 |
GO:0016769 | transferase activity, transferring nitrogenous groups | 0.0432867010868868 |
GO:0006112 | energy reserve metabolic process | 0.0432867010868868 |
GO:0019748 | secondary metabolic process | 0.0480042215885874 |
GO:0006418 | tRNA aminoacylation for protein translation | 0.0480042215885874 |
GO:0043038 | amino acid activation | 0.0480042215885874 |
GO:0043039 | tRNA aminoacylation | 0.0480042215885874 |
GO:0030170 | pyridoxal phosphate binding | 0.0480042215885874 |
GO:0005976 | polysaccharide metabolic process | 0.0480042215885874 |
GO:0005496 | steroid binding | 0.0480042215885874 |
GO:0003707 | steroid hormone receptor activity | 0.0480042215885874 |
GO:0044264 | cellular polysaccharide metabolic process | 0.0480042215885874 |
GO:0004879 | ligand-dependent nuclear receptor activity | 0.0480042215885874 |
GO:0016876 | ligase activity, forming aminoacyl-tRNA and related compounds | 0.0480042215885874 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 0.0480042215885874 |
GO:0004812 | aminoacyl-tRNA ligase activity | 0.0480042215885874 |
GO:0009059 | macromolecule biosynthetic process | 0.0495027323876971 |
Relative expression of the co-expression cluster over median <br>Analyst:
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |